Voyager Therapeutics (VYGR) Amortizatization of Intangibles (2015 - 2026)
Voyager Therapeutics (VYGR) reported Amortizatization of Intangibles of $365000.0 for Q1 2026, down 63.43% on a YoY basis from $998000.0 in Q1 2025, and down 31.13% sequentially from $530000.0 in Q4 2025.
Voyager Therapeutics (VYGR) Amortizatization of Intangibles (2015 - 2026) Analysis & Trends
Voyager Therapeutics (VYGR) has 12 years of Amortizatization of Intangibles data on file, last reported at $365000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 63.43% year-over-year to $365000.0; the trailing twelve-month figure through Mar 2026 stood at $2.3 million (down 66.74% YoY), and the FY2025 full-year result was $3.0 million, down 62.69% from the prior year.
- Amortizatization of Intangibles slipped to $365000.0 in Q1 2026, from $530000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $2.5 million in Q2 2024 to a low of -$21000.0 in Q1 2022.
- A 5-year average of $879352.9 and a median of $654000.0 in 2025 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles jumped 30700.0% in 2024 and slumped 68.27% in 2025, its largest moves.
- Tracing VYGR's Amortizatization of Intangibles over 5 years: stood at -$7000.0 in 2022, then surged by 25728.57% to $1.8 million in 2023, then slipped by 15.66% to $1.5 million in 2024, then sank by 64.97% to $530000.0 in 2025, then slumped by 31.13% to $365000.0 in 2026.
- Business Quant data shows VYGR's Amortizatization of Intangibles at $365000.0 in Q1 2026, $530000.0 in Q4 2025, and $654000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Voyager Therapeutics | 183.25 Mn | 41.77 Mn | - | 365,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 365,000.00 |
| Mar 31, 2026 | 365,000.00 |
| Dec 31, 2025 | 530,000.00 |
| Dec 31, 2025 | 530,000.00 |
| Sep 30, 2025 | 654,000.00 |
| Sep 30, 2025 | 654,000.00 |
| Jun 30, 2025 | 791,000.00 |
| Jun 30, 2025 | 791,000.00 |
| Mar 31, 2025 | 998,000.00 |
| Mar 31, 2025 | 998,000.00 |
| Dec 31, 2024 | 1.51 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 2.06 Mn |
| Sep 30, 2024 | 2.06 Mn |
| Jun 30, 2024 | 2.46 Mn |
| Jun 30, 2024 | 2.46 Mn |
| Mar 31, 2024 | 1.93 Mn |
| Mar 31, 2024 | 1.93 Mn |
| Dec 31, 2023 | 1.79 Mn |
| Dec 31, 2023 | 1.79 Mn |